Next Article in Journal
Trends in Avoidable Mortality in Lithuania During 2001–2008 and Their Impact on Life Expectancy
Previous Article in Journal
Growth Factors, Their Receptors, Neuropeptide-Containing Innervation, and Matrix Metalloproteinases in the Proximal and Distal Ends of the Esophagus in Children With Esophageal Atresia
Article Menu
Issue 2 (May) cover image

Export Article

Open AccessArticle
Medicina 2018, 54(2), 16; https://doi.org/10.3390/medicina54020016

Comparison of the Effects of Subconjunctival Injections of Bevacizumab and Interferon Alpha-2a on Corneal Angiogenesis in a Rat Model

Department of Ophthalmology, Sifa University, Izmir 35100, Turkey
Received: 21 February 2018 / Revised: 9 April 2018 / Accepted: 13 April 2018 / Published: 16 April 2018
Full-Text   |   PDF [9618 KB, uploaded 3 May 2018]   |  

Abstract

Background and objective: Corneal neovascularization (CNV) is a vision-threatening condition arising from various corneal diseases. The aim of this study is to compare the effectiveness of bevacizumab and interferon alpha-2a (IFNα-2a) treatment on corneal neovascularization. Materials and Methods: Twenty-four Wistar albino rats were used in this study. After cauterization of the cornea with a silver nitrate applicator stick, the control group received 0.1 mL saline solution, the second group received 0.1 mL IFNα-2a (IFNα-2a, 6 million international units [MIU]/0.5 mL), and the third group received 2.5 mg bevacizumab by subconjunctival injection. An additional injection was administered to each group on the fourth day. After one week, the corneal neovascularization rate and the longest neovascular sprout length were determined. Results: The neovascularization rate (saline 0.65 ± 0.05; IFNα-2a 0.62 ± 0.07; bevacizumab 0.42 ± 0.11) with bevacizumab was significantly lower, more than those with IFNα-2a and saline (p < 0.001 and p < 0.001). The longest neovascular sprout length (saline, 4.00 ± 0.6 mm; IFNα-2a, 3.63 ± 0.52 mm; bevacizumab, 2.81 ± 0.65 mm) with bevacizumab was significantly shorter than those with saline and IFNα-2a (p = 0.001 and p = 0.012). Conclusions: Subconjunctival IFNα-2a has limited efficacy in the treatment of corneal neovascularization. View Full-Text
Keywords: corneal neovascularization rate; corneal neovascular sprout length; bevacizumab; interferon alpha-2a corneal neovascularization rate; corneal neovascular sprout length; bevacizumab; interferon alpha-2a
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Bilgin, S. Comparison of the Effects of Subconjunctival Injections of Bevacizumab and Interferon Alpha-2a on Corneal Angiogenesis in a Rat Model. Medicina 2018, 54, 16.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Medicina EISSN 1010-660X Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top